Literature DB >> 18413478

Impaired eye movements in presymptomatic spinocerebellar ataxia type 6.

Peka Christova1, John H Anderson, Christopher M Gomez.   

Abstract

BACKGROUND: Early detection of impaired neurological function in neurodegenerative diseases may aid in understanding disease pathogenesis and timing of therapeutic trials.
OBJECTIVE: To identify early abnormalities of ocular motor function in individuals who have the spinocerebellar ataxia type 6 (SCA6) gene (CACNA1A) but no clinical symptoms.
DESIGN: Physiological techniques were used to record and analyze eye movements and postural sway. PATIENTS: Four presymptomatic and 5 ataxic patients with SCA6, genetically identified, and 10 healthy controls.
RESULTS: Presymptomatic individuals had normal postural sway but definite ocular motor abnormalities. Two had a low-amplitude horizontal gaze-evoked nystagmus, 1 of whom had a significantly decreased eye velocity for upward saccades and an abnormal frequency of square-wave jerks. Another had abnormal square-wave jerks and a fourth had a reduced gain for pursuit tracking. Not all of the presymptomatic patients had the same findings, but a multivariate analysis discriminated the presymptomatic patients, as a group, from healthy controls and the ataxic patients.
CONCLUSIONS: Among the earliest functional deficits in SCA6 are eye movement abnormalities, including impaired saccade velocity, saccade metrics, and pursuit gain. This suggests that early functional impairments are caused by cellular dysfunction and/or loss in the posterior cerebellar vermis and flocculus. These findings might help to determine the timing of a treatment and to define variables that could be used as outcome measures for the efficacy of therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413478     DOI: 10.1001/archneur.65.4.530

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

Review 1.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

Review 2.  [The presymptomatic stage of neurodegenerative disorders].

Authors:  C Klein; J Hagenah; B Landwehrmeyer; T Münte; T Klockgether
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

3.  Early Cerebellar Network Shifting in Spinocerebellar Ataxia Type 6.

Authors:  M I Falcon; C M Gomez; E E Chen; A Shereen; A Solodkin
Journal:  Cereb Cortex       Date:  2015-07-24       Impact factor: 5.357

4.  Ocular Motor Findings Aid in Differentiation of Spinocerebellar Ataxia Type 17 from Huntington's Disease.

Authors:  Sun-Uk Lee; Ji-Soo Kim; Dallah Yoo; Aryun Kim; Hyo-Jung Kim; Jeong-Yoon Choi; Ji-Yun Park; Seong-Hae Jeong; Jong-Min Kim; Kun-Woo Park
Journal:  Cerebellum       Date:  2022-01-07       Impact factor: 3.847

Review 5.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

6.  Digital Phenotyping in Clinical Neurology.

Authors:  Anoopum S Gupta
Journal:  Semin Neurol       Date:  2022-01-11       Impact factor: 3.212

7.  Evolution of the vestibular function during head impulses in spinocerebellar ataxia type 6.

Authors:  Sun-Uk Lee; Ji-Soo Kim; Hyo-Jung Kim; Jeong-Yoon Choi; Ji-Yun Park; Jong-Min Kim; Xu Yang
Journal:  J Neurol       Date:  2020-02-17       Impact factor: 4.849

8.  Novel CACNA1A mutation(s) associated with slow saccade velocities.

Authors:  Stefan Kipfer; Simon Jung; Johannes R Lemke; Anna Kipfer-Kauer; Jeremy P Howell; Alain Kaelin-Lang; Thomas Nyffeler; Klemens Gutbrod; Angela Abicht; René M Müri
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

9.  Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3).

Authors:  Mafalda Raposo; João Vasconcelos; Conceição Bettencourt; Teresa Kay; Paula Coutinho; Manuela Lima
Journal:  BMC Neurol       Date:  2014-01-22       Impact factor: 2.474

10.  Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.

Authors:  Luis Velázquez-Perez; Rosalinda Díaz; Ruth Pérez-González; Nalia Canales; Roberto Rodríguez-Labrada; Jacquelín Medrano; Gilberto Sánchez; Luis Almaguer-Mederos; Cira Torres; Juan Fernandez-Ruiz
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.